4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-17-056529
SVP & Chief Scientific Officer sold 43,677 shares at $24.97 ($1,090,615)
- SVP & Chief Scientific Officer acquired 43,677 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Doberstein Stephen K SVP & Chief Scientific Officer | 2017-10-05 | Option exercise | +43,677 | $9.53 | $416,242 | 74,779 | D |
| Doberstein Stephen K SVP & Chief Scientific Officer | 2017-10-05 | Sale | −43,677 | $24.97 | $1,090,615 | 31,102 | D |
| Derivatives | |||||||
| Doberstein Stephen K SVP & Chief Scientific Officer | 2017-10-05 | Option exercise · Stock Option | −43,677 | 396,323 | D | ||
| Open-market sales · 43,677 sh · avg $24.97 · $1,090,615 | |||||||
Loading xslF345X03/doc4.xml…